Treatment of advanced neuroblastoma with two consecutive high-dose chemotherapy regimens and ABMT.
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002330:Carmustine / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007223:Infant; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D009447:Neuroblastoma / Q000401:mortality / Q000628:therapy*; D013713:Teniposide / Q000008:administration & dosage
D013713:Teniposide; D008558:Melphalan; D002330:Carmustine